Sinntaxis AB
PrivateCompany Overview
Sinntaxis AB is a biotechnology company that develops novel therapeutics to enhance the recovery of brain functions after stroke and other brain injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sinntaxis AB Comparables
Compare Sinntaxis AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synap Biotech | 81% | |
| Addex Therapeutics | 79% | |
| Alevian, Inc. | 78% | |
Sinntaxis AB Funding Rounds
Historical fundraising activity
Sinntaxis AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LU Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 21, 2025
Grew 400% QoQ from 1 to 5 employees.
Sinntaxis AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sinntaxis AB's valuation, stock price, and market status.